Integration of Whole-Genome Sequencing With Circulating Tumor DNA Analysis Captures Clonal Evolution and Tumor Heterogeneity in Non-V600 BRAF Mutant Colorectal Cancer

Clin Colorectal Cancer. 2020 Jun;19(2):132-136.e3. doi: 10.1016/j.clcc.2020.02.001. Epub 2020 Feb 10.
No abstract available

Keywords: Anti-epidermal growth factor receptor; Colon; Colorectal neoplasms; EGFR; ctDNA.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers, Tumor / blood
  • Biomarkers, Tumor / genetics*
  • Biopsy
  • Circulating Tumor DNA / blood
  • Circulating Tumor DNA / genetics*
  • Clonal Evolution
  • Colorectal Neoplasms / blood
  • Colorectal Neoplasms / drug therapy
  • Colorectal Neoplasms / genetics*
  • Colorectal Neoplasms / pathology
  • ErbB Receptors / antagonists & inhibitors
  • Genetic Heterogeneity
  • Humans
  • Liver / pathology
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / genetics*
  • Liver Neoplasms / secondary
  • Male
  • Mutation
  • Proto-Oncogene Proteins B-raf / genetics*
  • Whole Genome Sequencing

Substances

  • Biomarkers, Tumor
  • Circulating Tumor DNA
  • EGFR protein, human
  • ErbB Receptors
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf